Cancer Clinical Trial
Official title:
Getting Physical on Cigarettes: Exercise and Smoking Cessation - Preventing Relapse
| Verified date | June 2012 |
| Source | University of Western Ontario, Canada |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Canada: Ethics Review Committee |
| Study type | Interventional |
Adult female smokers will participate in an exercise-aided smoking cessation program, and
will then be randomized into one of four cessation maintenance conditions: (a) Exercise
Maintenance only (b) Exercise Maintenance + Relapse Prevention Booklets(c) Relapse
Prevention Booklets + Contact and (d) Contact Control. Primary follow-up outcome is smoking
behaviour. Secondary outcomes include exercise behaviour, Physiological measures (body
composition (Dual-emission X-ray absorptiometry; DXA), vascular health (stiffness,
endothelial function, carotid plaque volume), physical fitness), and Psychological measures
(self-regulatory cognitions related to exercise adherence [exercise, scheduling, barrier,
relapse, and concurrent self-regulatory self-efficacy]).
The hypotheses detailed below are specific to the randomization of participants into the
following 4 groups:
1. Exercise Maintenance only
2. Exercise Maintenance + Relapse Prevention Booklets
3. Relapse Prevention Booklets + Contact
4. Contact Control
Hypothesis 1: Compared to quitters in the contact control condition, quitters exposed to a
home-based lifestyle exercise maintenance intervention (Exercise Maintenance only and
Exercise Maintenance + Relapse Prevention Booklets) will demonstrate significantly greater
exercise adherence and fitness levels, as well as significantly less weight gain and smoking
relapse rates following exercise-aided smoking cessation program termination.
Hypothesis 2: Compared to quitters in the contact control condition, quitters exposed to
relapse information only (Relapse Prevention Booklets + Contact) will experience
significantly less smoking relapse following exercise-aided smoking cessation program
termination.
Due to the novelty and exploratory nature of the respective prevention programs, no
hypotheses are specified with respect to which prevention program (exercise maintenance or
relapse prevention information) will be superior to the other, or whether the additive
benefits (i.e., exercise maintenance plus relapse prevention information) will be superior
to one prevention program alone.
| Status | Completed |
| Enrollment | 413 |
| Est. completion date | April 2014 |
| Est. primary completion date | April 2014 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 18 Years to 65 Years |
| Eligibility |
Participants must meet the following criteria: - Between the ages of 18 and 65 - Smoking greater than 10 cigarettes per day, have done so for the past 2 years, and want to quit - Engage in 2 or less 30-minute bouts of moderate or vigorous intensity exercise over the past 6 months - Absence of any medical condition that is contraindicative for exercise - not pregnant or intending on being pregnant over the course of the study - Be able to read and write in English - Have a telephone or an email account that we can reach you at Exclusion criteria include: - Contraindication to regular exercise (e.g., disability, unstable angina) - Contraindications to using nicotine replacement therapy (NRT) - Currently exercise more than twice a week for 30 or more minutes each bout at a moderate to vigorous intensity level and have done so for the past 6 months - On medication for physical and/or mental health reasons that would make compliance with the study protocol difficult or dangerous - Have substance dependency problems (e.g., alcohol) - Are pregnant or are planning on becoming pregnant during the next year - No Medical Doctor approval for exercise or NicoDerm patch (Nicotine Replacement Therapy; NRT) |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention
| Country | Name | City | State |
|---|---|---|---|
| Canada | Exercise and Health Psychology Laboratory - The University of Western Ontario | London | Ontario |
| Lead Sponsor | Collaborator |
|---|---|
| University of Western Ontario, Canada | Canadian Cancer Society Research Institute (CCSRI) |
Canada,
Brandon TH, Collins BN, Juliano LM, Lazev AB. Preventing relapse among former smokers: a comparison of minimal interventions through telephone and mail. J Consult Clin Psychol. 2000 Feb;68(1):103-13. — View Citation
Brandon TH, Meade CD, Herzog TA, Chirikos TN, Webb MS, Cantor AB. Efficacy and cost-effectiveness of a minimal intervention to prevent smoking relapse: dismantling the effects of amount of content versus contact. J Consult Clin Psychol. 2004 Oct;72(5):797-808. — View Citation
Marcus BH, Albrecht AE, King TK, Parisi AF, Pinto BM, Roberts M, Niaura RS, Abrams DB. The efficacy of exercise as an aid for smoking cessation in women: a randomized controlled trial. Arch Intern Med. 1999 Jun 14;159(11):1229-34. — View Citation
Prapavessis H, Cameron L, Baldi JC, Robinson S, Borrie K, Harper T, Grove JR. The effects of exercise and nicotine replacement therapy on smoking rates in women. Addict Behav. 2007 Jul;32(7):1416-32. Epub 2006 Nov 9. — View Citation
Schnoll RA, Patterson F, Wileyto EP, Tyndale RF, Benowitz N, Lerman C. Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study. Pharmacol Biochem Behav. 2009 Mar;92(1):6-11. doi: 10.1016/j.pbb.2008.10.016. Epub 2008 Oct 31. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Smoking Behaviour | Continuous smoking behaviour will be measured from week 4-week 14, week26, week 56 (one year following quit). Smoking behaviour will be measured via self-report, breath Carbon Monoxide less than 6 parts per million, saliva cotinine. | 56 weeks post participant start date | No |
| Secondary | Exercise Behaviour | Exercise behaviour will be measured via Actical accelerometer at baseline, week 14, week 26 and week 56. | for 56 weeks post participant start | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|